Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Versus Originator Insulin Aspart Mix 70/30 (novomix 30) in People with Diabetes: A 26-Week, Randomized, Open-Label Trial (GEMELLI M)
Diabetes Therapy(2022)
Key words
Biosimilar,GEMELLI M,Insulin aspart mix,Premix,SAR341402
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined